Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 4355-4360, October 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esnault, C.
Right arrow Articles by Pecq, J. B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esnault, C.
Right arrow Articles by Pecq, J. B. L.

Effects of New Antitumor Bifunctional Intercalators Derived from 7H-Pyridocarbazole on Sensitive and Resistant L1210 Cells1

Catherine Esnault2, Bernard P. Roques, Alain Jacquemin-Sablon and Jean Bernard Le Pecq

Laboratoire de Pharmacologie Moléculaire (Centre National de la Recherche Scientifique LA 147, Institut National de la Santé et de la Recherche Médicale U 140), Institut Gustave Roussy, 94805 Villejulf Cedex [C. E., A. J-S., J. B. L.], and Département de Chimie Organique, ERA 613 du Centre National de la Recherche Scientifique et U 266 de l'Institut National de la Santé et de la Recherche Médicale, Unité d'Enseignement et de Recherche des Sciences Pharmaceutiques et Biologiques, 4 avenue de l'Observatoire, 75006 Paris [B. P. R.], France

The antitumor properties of 7H-pyridocarbazole dimers, a new series of bifunctional intercalators, have recently been described (Pelaprat, D., Delbarre, A., Le Guen, I., Roques, B. P., and Le Pecq, J. B. J. Med. Chem., 23: 1336–1343, 1980; and Roques, B. P., Pelaprat, D., Le Guen, I., Porcher, G., Gosse, C., and Le Pecq, J. B. Biochem. Pharmacol., 28: 1811–1815, 1979). In order to study the mechanism of action of these compounds, an L1210 subline was made resistant to one dimer (NSC 335153; ditercalinium). Selection of resistant cells was based on an in vitro-in vivo procedure as follows. Ascitic cells were taken from a leukemic mouse and incubated in vitro with the dimer for 1 hr. They were then injected into mice. After the development of the ascites, L1210 cells were collected and the process was repeated 13 times, until establishment of the resistance. Cloned resistant cells have maintained their resistance for 18 months of in vitro culture. The effects of two dimers (NSC 335153 and NSC 335154) on cell viability, growth, colony formation, and cell cycle progression were investigated on parental and resistant L1210 cells. The cross-resistance of these two L1210 cell lines to several cytotoxic agents was estimated. Several observations indicate that the mechanism of action of these dimers might be different from that of monointercalating agents: (a) these drugs induce a delayed toxicity (growth arrest occurring five generations after drug exposure) in sensitive but not in resistant cells; (b) cells exposed to the dimers arrested almost randomly in all phases of the cell cycle, whereas the corresponding monomer provokes a block in the G2 + M phase. Resistant cells were cross-resistant to 7H-pyridocarbazole monomer, Adriamycin, and vincristine but not to 6H-pyridocarbazole monomer derivatives, actinomycin D, and methotrexate.

1 Supported in part by grants from Université P. M. Curie (Paris VI, UER Biochimie), Association pour la Recherche sur le Cancer, and Fondation pour la Recherche Médicale Française.

2 To whom requests for reprints should be addressed, at the Institute Gustave Roussy, 53 rue Camille Desmoulins, 94805 Villejuif Cedex, France.

Received 2/28/84. Accepted 6/22/84.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
T. Berge, N. S. Jenkins, R. B. Hopkirk, M. J. Waring, J. M. Edwardson, and R. M. Henderson
Structural perturbations in DNA caused by bis-intercalation of ditercalinium visualised by atomic force microscopy
Nucleic Acids Res., July 1, 2002; 30(13): 2980 - 2986.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.